Sleepstation is a clinically proven treatment for insomnia.
Insomnia disorder is highly prevalent in the general population, and a number of epidemiological studies estimate prevalence at 10%–12%.
Defined as difficulty initiating sleep, difficulty maintaining sleep, with subsequent impact upon daytime function, insomnia disorder is associated with daytime fatigue, reduced quality of life, and increased ill health across a range of studies.
Insomnia predicts subsequent depression or anxiety in those with a first episode of mood disorder and is also associated with physical health problems such as hypertension and diabetes.
There is a large body of evidence, based on over 20 years of randomised controlled trials (RCTs), for a specific form of cognitive behavioural therapy (CBT), CBT for insomnia (CBT-i), being an effective and long-lasting treatment for 50%–70% of patients.
Pharmacological therapies are widely used in primary care, but there is limited evidence for their benefit in chronic insomnia and increasing evidence that these medications are associated with long-term risks, particularly in an older population.
The efficacy of CBT-i to improve outcomes in primary and co-morbid insomnia patients has been repeatedly demonstrated, with improvements in both mental and physical health outcomes.
Several small-cohort studies and two RCTs to date have evaluated online CBT-i and shown promising results but with varying effect sizes.
CBT-i tackles factors that maintain insomnia over time, including sleep-related dysfunctional cognitions, behaviours which perpetuate insomnia, and dysregulation of the homeostatic sleep drive.
In the most recent study into the effectiveness of sleepstation, there was a significant increase in sleep efficiency and sleep latency after intervention; with modest improvements in total sleep time. The majority of users reported improved sleep quality. It was concluded that online CBT-i can be designed to deliver personalised therapy with good reported outcomes and high compliance rates in those who start therapy.